Marshall Wace, LLP Neuro Pace Inc Transaction History

Marshall Wace, LLP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$6.38 - $15.33 $167,876 - $403,378	-26,313 Reduced 45.09%	32,045 $242,000
Q1 2024 May 15, 2024	BUY	$9.78 - $17.5 $432,148 - $773,272	44,187 Added 311.81%	58,358 $770,000
Q4 2023 Feb 14, 2024	BUY	$5.9 - $10.31 $83,608 - $146,103	14,171 New	14,171 $146,000
Q3 2021 Nov 15, 2021	SELL	$15.85 - $25.07 $236,783 - $374,520	-14,939 Closed	0 $0
Q2 2021 Aug 25, 2021	BUY	$19.03 - $26.5 $284,289 - $395,883	14,939 New	14,939 $355,000

21.3M

1.3K

100

Ticker NPCE
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 24,846,900
Market Cap $241M
Description
NeuroPace, Inc. operates as a medical device company in the United States. It develops and sells RNS system, a brain-responsive neuromodulation system for treating medically refractory focal epilepsy by delivering personalized real-time treatment at the seizure source. The company's RNS system also records continuous brain activity data; and ena...

Get notified when there are updates to the investment portfolio of Marshall Wace, LLP, based on Form 13F filings with the SEC.

Stay updated on Marshall Wace, LLP with notifications on news.